A fixed-dose combination (FDC) of two nootropic agents with complementary mechanisms of action, primarily used for the management of cognitive deficits, post-stroke recovery, and age-related cognitive decline. Citicoline is a source of choline and cytidine, essential for phosphatidylcholine synthesis and membrane repair. Piracetam is a cyclic derivative of GABA, a classic racetam nootropic that modulates neurotransmission, membrane fluidity, and cerebral metabolism. This combination is widely prescribed in India for neuroenhancement and neuroprotection.
Adult: One tablet (Citicoline 500mg + Piracetam 800mg) twice daily, preferably with meals. May be initiated at once daily for tolerance.
Note: Administer orally with a full glass of water, preferably with food to minimize potential GI upset. Do not crush or chew unless advised. Maintain adequate hydration.
The combination works synergistically. Citicoline provides the rate-limiting precursors (choline and cytidine) for the synthesis of phosphatidylcholine, a critical neuronal membrane phospholipid, and increases acetylcholine synthesis. Piracetam modulates neuronal and vascular function, enhancing membrane fluidity, facilitating interhemispheric communication via the corpus callosum, and potentially stabilizing mitochondrial membranes. Together, they promote membrane repair, enhance neurotransmission (particularly cholinergic and glutamatergic), improve cerebral microcirculation, and reduce free fatty acid accumulation during ischemia.
Pregnancy: Category B (US FDA classification not assigned for FDC). Animal studies show no risk, but human data insufficient. Use only if potential benefit justifies potential risk to fetus. Not recommended during pregnancy.
Driving: May cause dizziness, drowsiness, or blurred vision. Patients should not drive or operate machinery until their response is known.
| Anticoagulants (Warfarin, Acenocoumarol) & Antiplatelets (Clopidogrel, Aspirin) | Piracetam may inhibit platelet aggregation; additive risk of bleeding. Monitor INR and for bruising/bleeding. | Major |
| Antihypertensives | Piracetam may cause hypotension; additive effect. Monitor BP. | Moderate |
| Levodopa/Carbidopa | Piracetam may potentiate effects, potentially worsening dyskinesias in Parkinson's disease. | Moderate |
| Thyroid hormones | Piracetam may increase T4 levels; monitor thyroid function. | Moderate |
| Other CNS stimulants (Modafinil, Methylphenidate) | Additive stimulant effects, may increase nervousness and insomnia. | Moderate |
Same composition (Citicoline (500mg) + Piracetam (800mg)), different brands: